WASHINGTON, Sept. 2 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Peak Performance Peptides from its Center for Drug Evaluation and Research:

* * *

Recipient: Jeffrey Deng, Founder, Peak Performance Peptides, 3935 E Rough Rider Rd Unit 1016, Phoenix, AZ 85050, United States, contact@pppepz.com, (b)(6), (b)(7)(C)

Issuing Office: Center for Drug Evaluation and Research (CDER), United St . . .

Click here for more information about our products